{"log_id": 3911987927682397237, "direction": 0, "words_result_num": 214, "words_result": [{"probability": {"variance": 3.1e-05, "average": 0.996514, "min": 0.98689}, "location": {"width": 68, "top": 25, "height": 21, "left": 289}, "words": "眼部异常"}, {"probability": {"variance": 0.020265, "average": 0.91108, "min": 0.552747}, "location": {"width": 350, "top": 23, "height": 21, "left": 570}, "words": "脓毒血症性休克、憩室炎、以及脓实验室评价"}, {"probability": {"variance": 8e-06, "average": 0.991867, "min": 0.989085}, "location": {"width": 33, "top": 52, "height": 18, "left": 292}, "words": "偶见"}, {"probability": {"variance": 0.000208, "average": 0.991582, "min": 0.958384}, "location": {"width": 128, "top": 49, "height": 21, "left": 379}, "words": "葡萄膜炎,巩膜炎"}, {"probability": {"variance": 0.007622, "average": 0.970164, "min": 0.647982}, "location": {"width": 230, "top": 44, "height": 20, "left": 569}, "words": "肿。在双育开放标签的银屑病关节"}, {"probability": {"variance": 1e-06, "average": 0.999459, "min": 0.996911}, "location": {"width": 200, "top": 44, "height": 20, "left": 872}, "words": "根据临床研究的结果,对患者"}, {"probability": {"variance": 0.000385, "average": 0.990321, "min": 0.930585}, "location": {"width": 167, "top": 71, "height": 22, "left": 307}, "words": "参见下文“其他不良反应"}, {"probability": {"variance": 0.001448, "average": 0.986279, "min": 0.802714}, "location": {"width": 487, "top": 65, "height": 20, "left": 569}, "words": "炎试验中,1例患者报告严重感染除了仔细的医疗处置和监测外通"}, {"probability": {"variance": 0, "average": 0.9998, "min": 0.999394}, "location": {"width": 98, "top": 97, "height": 19, "left": 292}, "words": "其他不良反应"}, {"probability": {"variance": 0.004167, "average": 0.935327, "min": 0.870776}, "location": {"width": 39, "top": 87, "height": 19, "left": 572}, "words": "肺炎"}, {"probability": {"variance": 1e-06, "average": 0.999222, "min": 0.996794}, "location": {"width": 185, "top": 86, "height": 20, "left": 854}, "words": "需要进行特殊的实验室评价"}, {"probability": {"variance": 0.000314, "average": 0.991778, "min": 0.928508}, "location": {"width": 430, "top": 106, "height": 21, "left": 602}, "words": "曾有使用本品发生严重和致命本品和阿那白滞素联合治疗"}, {"probability": {"variance": 0.000102, "average": 0.994563, "min": 0.967236}, "location": {"width": 213, "top": 120, "height": 21, "left": 291}, "words": "恶性肿瘤和淋巴组织增生疾病"}, {"probability": {"variance": 0.000348, "average": 0.990412, "min": 0.933986}, "location": {"width": 224, "top": 128, "height": 20, "left": 571}, "words": "感染的报告,报告的病原包括细菌"}, {"probability": {"variance": 0.00019, "average": 0.993994, "min": 0.947719}, "location": {"width": 200, "top": 129, "height": 19, "left": 874}, "words": "在对同时接受本品和阿那白滞"}, {"probability": {"variance": 0.006282, "average": 0.975464, "min": 0.690591}, "location": {"width": 204, "top": 142, "height": 18, "left": 322}, "words": "在4114名类风湿关节炎患者"}, {"probability": {"variance": 0.003022, "average": 0.981071, "min": 0.717609}, "location": {"width": 495, "top": 149, "height": 20, "left": 572}, "words": "分枝杆菌(含结核病)、病毒和真菌。素治疗的患者进行研究时发现与"}, {"probability": {"variance": 1e-05, "average": 0.998307, "min": 0.990571}, "location": {"width": 220, "top": 162, "height": 20, "left": 290}, "words": "使用本品达6年的临床试验中"}, {"probability": {"variance": 0.001851, "average": 0.986588, "min": 0.797305}, "location": {"width": 487, "top": 167, "height": 22, "left": 586}, "words": "些病例发生于开始使用本品治疗独使用本品相比,同时使用本品和"}, {"probability": {"variance": 0.00032, "average": 0.989258, "min": 0.943539}, "location": {"width": 219, "top": 182, "height": 20, "left": 293}, "words": "观察到各种新生恶性肿瘤129例"}, {"probability": {"variance": 0.000194, "average": 0.993721, "min": 0.940402}, "location": {"width": 497, "top": 189, "height": 22, "left": 572}, "words": "后的数周内,这些患者除了类风湿阿那白滞素治疗时严重感染的发生"}, {"probability": {"variance": 9.3e-05, "average": 0.993832, "min": 0.965595}, "location": {"width": 231, "top": 203, "height": 22, "left": 292}, "words": "其中包括联合甲氨蝶呤和本品治疗"}, {"probability": {"variance": 0.001127, "average": 0.988088, "min": 0.819237}, "location": {"width": 485, "top": 210, "height": 20, "left": 574}, "words": "关节炎之外还患有基础疾病(糖尿率更高并且有2%3/139的"}, {"probability": {"variance": 0.000504, "average": 0.992188, "min": 0.914732}, "location": {"width": 216, "top": 223, "height": 21, "left": 306}, "words": "年的活性对照试验的231名"}, {"probability": {"variance": 0.000537, "average": 0.986383, "min": 0.911243}, "location": {"width": 502, "top": 231, "height": 19, "left": 570}, "words": "病、充血性心力衰竭、活动性或慢者出现中性粒细胞减少(绝对中性"}, {"probability": {"variance": 6.1e-05, "average": 0.99663, "min": 0.968319}, "location": {"width": 234, "top": 245, "height": 20, "left": 292}, "words": "者。这些临床试验中所观察到的比"}, {"probability": {"variance": 0.005468, "average": 0.960137, "min": 0.731646}, "location": {"width": 201, "top": 251, "height": 21, "left": 571}, "words": "性感染)(参见“注意事项)"}, {"probability": {"variance": 0.001777, "average": 0.974788, "min": 0.858159}, "location": {"width": 127, "top": 254, "height": 17, "left": 841}, "words": "粒细胞计数<1000"}, {"probability": {"variance": 0, "average": 0.975515, "min": 0.975515}, "location": {"width": 15, "top": 253, "height": 16, "left": 1024}, "words": "其"}, {"probability": {"variance": 3e-05, "average": 0.996758, "min": 0.980094}, "location": {"width": 234, "top": 265, "height": 22, "left": 293}, "words": "率和发病率与对全体人口的研究期"}, {"probability": {"variance": 0.008828, "average": 0.973818, "min": 0.491798}, "location": {"width": 501, "top": 273, "height": 19, "left": 572}, "words": "项临床试验表明,本品治疗可能增名患者并发蜂窝组织炎,经住院治"}, {"probability": {"variance": 0.000146, "average": 0.99361, "min": 0.953837}, "location": {"width": 234, "top": 285, "height": 21, "left": 291}, "words": "望值相同。在一项351名采用本"}, {"probability": {"variance": 0.000554, "average": 0.991818, "min": 0.910789}, "location": {"width": 205, "top": 294, "height": 19, "left": 569}, "words": "加患有脓毒血症患者的死亡率"}, {"probability": {"variance": 0.001514, "average": 0.980711, "min": 0.886735}, "location": {"width": 104, "top": 294, "height": 18, "left": 842}, "words": "疗后康复(参见"}, {"probability": {"variance": 0.062007, "average": 0.870997, "min": 0.372998}, "location": {"width": 71, "top": 292, "height": 20, "left": 1004}, "words": "项和“药"}, {"probability": {"variance": 0.002282, "average": 0.983647, "min": 0.81339}, "location": {"width": 229, "top": 307, "height": 19, "left": 293}, "words": "品治疗2年以上的强直性脊柱炎"}, {"probability": {"variance": 7e-06, "average": 0.998001, "min": 0.991393}, "location": {"width": 184, "top": 316, "height": 19, "left": 602}, "words": "曾有机会致病菌感染的报告"}, {"probability": {"variance": 0.000184, "average": 0.992878, "min": 0.960032}, "location": {"width": 94, "top": 315, "height": 19, "left": 842}, "words": "物相互作用”)"}, {"probability": {"variance": 0.008199, "average": 0.97119, "min": 0.633853}, "location": {"width": 226, "top": 329, "height": 19, "left": 293}, "words": "患者的研究中,本品治疗组报告了"}, {"probability": {"variance": 0.001006, "average": 0.980562, "min": 0.882691}, "location": {"width": 232, "top": 335, "height": 20, "left": 570}, "words": "包括侵袭性真菌感染、寄生虫(包"}, {"probability": {"variance": 0.001648, "average": 0.981153, "min": 0.851394}, "location": {"width": 219, "top": 349, "height": 21, "left": 308}, "words": "例恶性肿瘤。在治疗其它适应症"}, {"probability": {"variance": 0.000994, "average": 0.980643, "min": 0.896169}, "location": {"width": 317, "top": 356, "height": 19, "left": 569}, "words": "括原虫)感染、细菌感染(包括利【禁忌】"}, {"probability": {"variance": 0.000203, "average": 0.993543, "min": 0.94502}, "location": {"width": 234, "top": 369, "height": 20, "left": 293}, "words": "的患者中,报告了32例恶性肿瘤"}, {"probability": {"variance": 0.000453, "average": 0.988243, "min": 0.914628}, "location": {"width": 228, "top": 378, "height": 18, "left": 573}, "words": "斯塔氏菌属和军团病杆菌属)以及"}, {"probability": {"variance": 0.027891, "average": 0.922757, "min": 0.522716}, "location": {"width": 182, "top": 391, "height": 19, "left": 291}, "words": "和43例非黑色素瘤皮肤癌"}, {"probability": {"variance": 6e-06, "average": 0.997222, "min": 0.992626}, "location": {"width": 201, "top": 381, "height": 19, "left": 874}, "words": "对本品活性成份或制剂中其他"}, {"probability": {"variance": 2e-05, "average": 0.997153, "min": 0.985514}, "location": {"width": 201, "top": 411, "height": 19, "left": 323}, "words": "在临床试验中有4410名成年"}, {"probability": {"variance": 0.011261, "average": 0.968571, "min": 0.515469}, "location": {"width": 340, "top": 398, "height": 22, "left": 573}, "words": "非典型分枝杆菌感染。在一项综合成份过敏者"}, {"probability": {"variance": 7.7e-05, "average": 0.995438, "min": 0.969454}, "location": {"width": 231, "top": 418, "height": 19, "left": 571}, "words": "的临床试验数据中,15402名本品"}, {"probability": {"variance": 2.7e-05, "average": 0.996649, "min": 0.98457}, "location": {"width": 218, "top": 430, "height": 21, "left": 291}, "words": "银屑病应用本品治疗至36个月"}, {"probability": {"variance": 0.001745, "average": 0.981742, "min": 0.851378}, "location": {"width": 155, "top": 422, "height": 19, "left": 918}, "words": "患者或存在败血症风险的"}, {"probability": {"variance": 7e-06, "average": 0.996222, "min": 0.988828}, "location": {"width": 237, "top": 452, "height": 20, "left": 290}, "words": "约4278患者年,淋巴瘤的发生率"}, {"probability": {"variance": 0.008939, "average": 0.971876, "min": 0.606737}, "location": {"width": 295, "top": 440, "height": 21, "left": 571}, "words": "治疗患者出现机会致病菌感染的总患"}, {"probability": {"variance": 0.00035, "average": 0.990505, "min": 0.922459}, "location": {"width": 230, "top": 460, "height": 18, "left": 571}, "words": "体发生率为0.09%。调整后暴露率"}, {"probability": {"variance": 0.001265, "average": 0.982941, "min": 0.893088}, "location": {"width": 230, "top": 473, "height": 19, "left": 293}, "words": "为每100个患者年0.05例,该发"}, {"probability": {"variance": 0.003607, "average": 0.980218, "min": 0.772648}, "location": {"width": 199, "top": 463, "height": 20, "left": 874}, "words": "包括慢性或局部感染在内的严"}, {"probability": {"variance": 0.004159, "average": 0.975528, "min": 0.751239}, "location": {"width": 207, "top": 481, "height": 18, "left": 574}, "words": "是每100个患者年中发生0.04"}, {"probability": {"variance": 2.7e-05, "average": 0.997123, "min": 0.981937}, "location": {"width": 233, "top": 493, "height": 20, "left": 293}, "words": "生率和普通人群相当。另外,在上"}, {"probability": {"variance": 0.000691, "average": 0.987844, "min": 0.929055}, "location": {"width": 98, "top": 484, "height": 19, "left": 870}, "words": "动性感染患者"}, {"probability": {"variance": 4e-06, "average": 0.996867, "min": 0.994747}, "location": {"width": 30, "top": 503, "height": 16, "left": 573}, "words": "事件"}, {"probability": {"variance": 0.000951, "average": 0.986835, "min": 0.895937}, "location": {"width": 152, "top": 502, "height": 17, "left": 649}, "words": "后,全球范围内出现机"}, {"probability": {"variance": 7e-06, "average": 0.998044, "min": 0.990364}, "location": {"width": 233, "top": 513, "height": 22, "left": 294}, "words": "述的有对照的临床试验中,本品组"}, {"probability": {"variance": 0.006087, "average": 0.974595, "min": 0.683611}, "location": {"width": 234, "top": 534, "height": 21, "left": 293}, "words": "和安慰剂组患者均未观察到淋巴瘤"}, {"probability": {"variance": 0.003781, "average": 0.977345, "min": 0.785891}, "location": {"width": 331, "top": 522, "height": 22, "left": 584}, "words": "致病菌感染的病例中约有一半为注意事项"}, {"probability": {"variance": 0.000829, "average": 0.985179, "min": 0.882419}, "location": {"width": 230, "top": 541, "height": 19, "left": 572}, "words": "侵袭性真菌感染。最常报告的侵袭"}, {"probability": {"variance": 0, "average": 0.999246, "min": 0.998581}, "location": {"width": 32, "top": 557, "height": 19, "left": 293}, "words": "发生"}, {"probability": {"variance": 0.016946, "average": 0.916176, "min": 0.690714}, "location": {"width": 62, "top": 550, "height": 20, "left": 840}, "words": "特别普告"}, {"probability": {"variance": 7e-06, "average": 0.99768, "min": 0.99028}, "location": {"width": 230, "top": 563, "height": 18, "left": 571}, "words": "性真菌感染为肺囊虫属和曲霉菌属"}, {"probability": {"variance": 2e-06, "average": 0.999139, "min": 0.994447}, "location": {"width": 198, "top": 575, "height": 20, "left": 323}, "words": "在采用本品治疗类风湿关节炎"}, {"probability": {"variance": 0.003219, "average": 0.981325, "min": 0.769804}, "location": {"width": 230, "top": 583, "height": 18, "left": 572}, "words": "侵袭性真菌感染导致了一半以上机"}, {"probability": {"variance": 0.001232, "average": 0.98525, "min": 0.877452}, "location": {"width": 197, "top": 573, "height": 20, "left": 874}, "words": "曾有使用本品发生严重感染"}, {"probability": {"variance": 0.0001, "average": 0.996416, "min": 0.959707}, "location": {"width": 235, "top": 596, "height": 20, "left": 292}, "words": "强直性脊柱炎和其他适应症的临床"}, {"probability": {"variance": 0.009945, "average": 0.95538, "min": 0.695468}, "location": {"width": 229, "top": 603, "height": 19, "left": 572}, "words": "会致病菌感染患者的死亡。主要的"}, {"probability": {"variance": 0.000766, "average": 0.990005, "min": 0.892387}, "location": {"width": 213, "top": 594, "height": 18, "left": 853}, "words": "包括脓毒血症和结核病)的报告"}, {"probability": {"variance": 1.3e-05, "average": 0.996685, "min": 0.990572}, "location": {"width": 234, "top": 616, "height": 19, "left": 293}, "words": "试验中,7416名患者中总共报告"}, {"probability": {"variance": 0.003217, "average": 0.982135, "min": 0.770413}, "location": {"width": 229, "top": 624, "height": 20, "left": 572}, "words": "致命性结果出现在肺孢子虫性肺炎"}, {"probability": {"variance": 1.4e-05, "average": 0.997643, "min": 0.988574}, "location": {"width": 199, "top": 614, "height": 18, "left": 860}, "words": "些是致命感染。这些感染是由"}, {"probability": {"variance": 0.000358, "average": 0.988237, "min": 0.947609}, "location": {"width": 82, "top": 637, "height": 18, "left": 315}, "words": "18例淋巴瘤"}, {"probability": {"variance": 0.00018, "average": 0.992087, "min": 0.953554}, "location": {"width": 231, "top": 644, "height": 19, "left": 574}, "words": "未确定的系统性真菌感染以及曲霉"}, {"probability": {"variance": 0.000175, "average": 0.992292, "min": 0.954762}, "location": {"width": 230, "top": 634, "height": 19, "left": 843}, "words": "细菌、分枝杆菌、真菌,病毒和寄"}, {"probability": {"variance": 0.017449, "average": 0.961072, "min": 0.503496}, "location": {"width": 201, "top": 656, "height": 20, "left": 327}, "words": "上市后也报告了各种肿瘤,包"}, {"probability": {"variance": 0.005, "average": 0.976637, "min": 0.722584}, "location": {"width": 213, "top": 662, "height": 21, "left": 573}, "words": "菌病的患者中(参见“注意事项"}, {"probability": {"variance": 0.000285, "average": 0.993958, "min": 0.931025}, "location": {"width": 228, "top": 655, "height": 18, "left": 846}, "words": "生虫(包括原虫)引起的。也曾有"}, {"probability": {"variance": 0.003739, "average": 0.959969, "min": 0.835868}, "location": {"width": 87, "top": 677, "height": 20, "left": 295}, "words": "括乳腺癌、肺"}, {"probability": {"variance": 0.001406, "average": 0.971855, "min": 0.896116}, "location": {"width": 89, "top": 676, "height": 20, "left": 440}, "words": "瘤(参见“特"}, {"probability": {"variance": 9e-06, "average": 0.998283, "min": 0.990612}, "location": {"width": 214, "top": 676, "height": 17, "left": 860}, "words": "会致病菌感染的报告(包括军团"}, {"probability": {"variance": 0.000203, "average": 0.982071, "min": 0.96079}, "location": {"width": 63, "top": 699, "height": 19, "left": 294}, "words": "别警告”)"}, {"probability": {"variance": 0.000208, "average": 0.991109, "min": 0.96617}, "location": {"width": 65, "top": 688, "height": 19, "left": 573}, "words": "自身抗体"}, {"probability": {"variance": 0.000957, "average": 0.987283, "min": 0.878024}, "location": {"width": 219, "top": 696, "height": 18, "left": 854}, "words": "属和利斯塔氏菌属)。需要对在"}, {"probability": {"variance": 3e-06, "average": 0.998621, "min": 0.9939}, "location": {"width": 186, "top": 719, "height": 18, "left": 343}, "words": "项临床试验中,曾有治疗"}, {"probability": {"variance": 0.012682, "average": 0.972693, "min": 0.391586}, "location": {"width": 472, "top": 712, "height": 24, "left": 602}, "words": "在多个时间点对患者的血清样本品治疗过程中出现新发感染的"}, {"probability": {"variance": 0.000166, "average": 0.994342, "min": 0.957983}, "location": {"width": 148, "top": 740, "height": 18, "left": 379}, "words": "芽肿患者出现恶性肿"}, {"probability": {"variance": 0.000465, "average": 0.989925, "min": 0.898311}, "location": {"width": 501, "top": 734, "height": 21, "left": 572}, "words": "本进行自身抗体检测。本品治疗组者进行严密监测。如果患者出现严"}, {"probability": {"variance": 3.6e-05, "average": 0.997476, "min": 0.979552}, "location": {"width": 157, "top": 761, "height": 17, "left": 295}, "words": "瘤的报告(参见临床试"}, {"probability": {"variance": 0.009248, "average": 0.972265, "min": 0.625561}, "location": {"width": 206, "top": 754, "height": 19, "left": 573}, "words": "类风湿关节炎患者抗核抗体(A"}, {"probability": {"variance": 9.9e-05, "average": 0.996414, "min": 0.959528}, "location": {"width": 233, "top": 757, "height": 19, "left": 842}, "words": "重感染必须停止使用本品。复发性"}, {"probability": {"variance": 3e-06, "average": 0.998414, "min": 0.996301}, "location": {"width": 97, "top": 782, "height": 17, "left": 293}, "words": "注射部位反应"}, {"probability": {"variance": 9e-05, "average": 0.99344, "min": 0.965903}, "location": {"width": 157, "top": 775, "height": 18, "left": 595}, "words": "度≥1:40)的阳性比例"}, {"probability": {"variance": 0.000437, "average": 0.991494, "min": 0.91716}, "location": {"width": 229, "top": 778, "height": 20, "left": 844}, "words": "或慢性感染的患者或存在可能导致"}, {"probability": {"variance": 0.000172, "average": 0.994206, "min": 0.951286}, "location": {"width": 192, "top": 799, "height": 22, "left": 328}, "words": "与安慰剂相比,使用本品治疗"}, {"probability": {"variance": 0.000813, "average": 0.990452, "min": 0.8577}, "location": {"width": 501, "top": 795, "height": 23, "left": 574}, "words": "大于安慰剂治疗组(5%)。通过放患者易受感染的潜在条件,当考虑"}, {"probability": {"variance": 0.024396, "average": 0.955185, "min": 0.392141}, "location": {"width": 227, "top": 820, "height": 22, "left": 294}, "words": "的风湿疾病患者的注射部位应"}, {"probability": {"variance": 0.009256, "average": 0.960682, "min": 0.598381}, "location": {"width": 472, "top": 815, "height": 23, "left": 572}, "words": "射性免疫测定法(本品治疗组15%使用本品治疗时,应谦慎使用"}, {"probability": {"variance": 5.4e-05, "average": 0.995356, "min": 0.97752}, "location": {"width": 217, "top": 841, "height": 21, "left": 295}, "words": "生率明显增高(本品治疗组36"}, {"probability": {"variance": 0.00902, "average": 0.969953, "min": 0.617122}, "location": {"width": 233, "top": 836, "height": 19, "left": 573}, "words": "安慰剂治疗组4%)和绿蝇短膜豆"}, {"probability": {"variance": 3.5e-05, "average": 0.996239, "min": 0.978896}, "location": {"width": 149, "top": 841, "height": 17, "left": 877}, "words": "本品和阿那白滞素(A"}, {"probability": {"variance": 0.000566, "average": 0.989383, "min": 0.904171}, "location": {"width": 232, "top": 862, "height": 19, "left": 294}, "words": "安慰剂组9%,包括红斑和/或瘙"}, {"probability": {"variance": 0.012593, "average": 0.950162, "min": 0.56152}, "location": {"width": 557, "top": 855, "height": 23, "left": 511}, "words": "瘙分析法(本品治疗组3%,安慰剂ra)联合治疗与严重感染和中性米"}, {"probability": {"variance": 0.00062, "average": 0.988357, "min": 0.899905}, "location": {"width": 229, "top": 882, "height": 19, "left": 294}, "words": "痒、疼痛或肿胀)。注射部位反应"}, {"probability": {"variance": 0.00153, "average": 0.985928, "min": 0.797392}, "location": {"width": 501, "top": 876, "height": 23, "left": 573}, "words": "治疗组0%)测得本品治疗患者抗细胞减少症的风险增加有关。由于"}, {"probability": {"variance": 0, "average": 0.999918, "min": 0.999851}, "location": {"width": 47, "top": 904, "height": 17, "left": 294}, "words": "通常在"}, {"probability": {"variance": 5.2e-05, "average": 0.995492, "min": 0.975569}, "location": {"width": 137, "top": 903, "height": 17, "left": 385}, "words": "月发生,且发生频率"}, {"probability": {"variance": 3.2e-05, "average": 0.996662, "min": 0.979006}, "location": {"width": 213, "top": 896, "height": 19, "left": 574}, "words": "双链DNA抗体阳性的比例较高"}, {"probability": {"variance": 2.1e-05, "average": 0.99807, "min": 0.981737}, "location": {"width": 213, "top": 902, "height": 17, "left": 846}, "words": "并未证实该联合治疗可以增加临"}, {"probability": {"variance": 0.000178, "average": 0.994048, "min": 0.950044}, "location": {"width": 220, "top": 923, "height": 19, "left": 294}, "words": "在第一个月最高,随后逐渐降低"}, {"probability": {"variance": 7.5e-05, "average": 0.995513, "min": 0.965764}, "location": {"width": 224, "top": 917, "height": 20, "left": 573}, "words": "本品治疗患者产生抗心磷脂抗体"}, {"probability": {"variance": 0.00057, "average": 0.984641, "min": 0.937593}, "location": {"width": 114, "top": 922, "height": 18, "left": 855}, "words": "效,因此不推荐"}, {"probability": {"variance": 0.00235, "average": 0.946459, "min": 0.879683}, "location": {"width": 44, "top": 923, "height": 17, "left": 1030}, "words": "那白滞"}, {"probability": {"variance": 8e-06, "average": 0.998257, "min": 0.991486}, "location": {"width": 233, "top": 944, "height": 18, "left": 295}, "words": "注射部位反应的平均持续时间为"}, {"probability": {"variance": 0.00542, "average": 0.975377, "min": 0.665687}, "location": {"width": 350, "top": 937, "height": 23, "left": 572}, "words": "增加比例与安慰剂组相似。长期使素联合使用"}, {"probability": {"variance": 3.6e-05, "average": 0.99632, "min": 0.978386}, "location": {"width": 206, "top": 965, "height": 18, "left": 321}, "words": "天。本品治疗组出现注射部位"}, {"probability": {"variance": 1.4e-05, "average": 0.997955, "min": 0.986457}, "location": {"width": 236, "top": 959, "height": 18, "left": 572}, "words": "用本品治疗对自身抗体产生的影响"}, {"probability": {"variance": 3.9e-05, "average": 0.996712, "min": 0.976038}, "location": {"width": 184, "top": 961, "height": 20, "left": 890}, "words": "项在180例标准治疗(包括"}, {"probability": {"variance": 0.006907, "average": 0.974278, "min": 0.663993}, "location": {"width": 232, "top": 985, "height": 20, "left": 295}, "words": "反应的患者大多数未予治疗,给予"}, {"probability": {"variance": 0.015868, "average": 0.873678, "min": 0.747708}, "location": {"width": 32, "top": 981, "height": 17, "left": 573}, "words": "未知"}, {"probability": {"variance": 0.00667, "average": 0.97343, "min": 0.668427}, "location": {"width": 228, "top": 982, "height": 19, "left": 846}, "words": "环磷酰胺和大剂量激素)上加用本"}, {"probability": {"variance": 4.7e-05, "average": 0.996053, "min": 0.978128}, "location": {"width": 231, "top": 1005, "height": 19, "left": 296}, "words": "治疗者中多数接受局部用药,例如"}, {"probability": {"variance": 0.005106, "average": 0.973444, "min": 0.639889}, "location": {"width": 472, "top": 998, "height": 24, "left": 603}, "words": "罕见报告患者(包括类风湿品的 Wegener i肉芽肿患者的安慰"}, {"probability": {"variance": 0.000609, "average": 0.986762, "min": 0.902573}, "location": {"width": 234, "top": 1023, "height": 22, "left": 295}, "words": "糖皮质激素或者口服抗组胺药。除"}, {"probability": {"variance": 0.003424, "average": 0.978635, "min": 0.730837}, "location": {"width": 424, "top": 1020, "height": 23, "left": 574}, "words": "因子阳性患者)产生其他自身抗剂对照研究中,与单用"}, {"probability": {"variance": 6e-06, "average": 0.998419, "min": 0.993053}, "location": {"width": 234, "top": 1045, "height": 20, "left": 294}, "words": "此之外,部分患者还出现注射部位"}, {"probability": {"variance": 0.005279, "average": 0.977545, "min": 0.670807}, "location": {"width": 348, "top": 1041, "height": 22, "left": 573}, "words": "体的同时出现狼疮样综合征或皮比,加用本"}, {"probability": {"variance": 0.004979, "average": 0.942734, "min": 0.804345}, "location": {"width": 98, "top": 1037, "height": 34, "left": 1000}, "words": "临床症状和"}, {"probability": {"variance": 3.3e-05, "average": 0.996593, "min": 0.983067}, "location": {"width": 105, "top": 1068, "height": 18, "left": 295}, "words": "反应再现,即在"}, {"probability": {"variance": 0.00086, "average": 0.989935, "min": 0.854902}, "location": {"width": 501, "top": 1060, "height": 25, "left": 406}, "words": "最近一次的注射点疹,这些皮疹与亚急性皮肤红斑改善更佳"}, {"probability": {"variance": 4e-06, "average": 0.99754, "min": 0.994993}, "location": {"width": 71, "top": 1066, "height": 17, "left": 1002}, "words": "患者与安慰"}, {"probability": {"variance": 0.00027, "average": 0.994198, "min": 0.932961}, "location": {"width": 231, "top": 1087, "height": 19, "left": 296}, "words": "有皮肤反应同时在多数的先前注射"}, {"probability": {"variance": 0.00042, "average": 0.991764, "min": 0.910308}, "location": {"width": 333, "top": 1081, "height": 22, "left": 573}, "words": "狼疮或盘状红斑狼疮的临床表现剂组相比"}, {"probability": {"variance": 5.6e-05, "average": 0.994671, "min": 0.980164}, "location": {"width": 89, "top": 1086, "height": 17, "left": 986}, "words": "非上皮恶性肿"}, {"probability": {"variance": 2.9e-05, "average": 0.998147, "min": 0.977982}, "location": {"width": 232, "top": 1108, "height": 19, "left": 296}, "words": "点也出现注射部位反应。这种反应"}, {"probability": {"variance": 0.021725, "average": 0.941869, "min": 0.552037}, "location": {"width": 135, "top": 1102, "height": 19, "left": 573}, "words": "和活组织检查相似"}, {"probability": {"variance": 0.001631, "average": 0.968471, "min": 0.911436}, "location": {"width": 45, "top": 1104, "height": 19, "left": 846}, "words": "瘤更多"}, {"probability": {"variance": 0.013558, "average": 0.898457, "min": 0.735215}, "location": {"width": 106, "top": 1096, "height": 34, "left": 1029}, "words": "肉芽肿"}, {"probability": {"variance": 0.005278, "average": 0.976601, "min": 0.705712}, "location": {"width": 227, "top": 1127, "height": 19, "left": 300}, "words": "一般为一过性的,而且治疗后不再"}, {"probability": {"variance": 0.00015, "average": 0.992436, "min": 0.971265}, "location": {"width": 62, "top": 1127, "height": 18, "left": 578}, "words": "免疫原性"}, {"probability": {"variance": 1.2e-05, "average": 0.996603, "min": 0.989963}, "location": {"width": 77, "top": 1127, "height": 17, "left": 846}, "words": "患者使用本"}, {"probability": {"variance": 0.001137, "average": 0.96384, "min": 0.930115}, "location": {"width": 34, "top": 1150, "height": 19, "left": 294}, "words": "复发"}, {"probability": {"variance": 3.3e-05, "average": 0.996843, "min": 0.979353}, "location": {"width": 200, "top": 1150, "height": 22, "left": 602}, "words": "在接受本品治疗的成年类风"}, {"probability": {"variance": 0.001994, "average": 0.959805, "min": 0.899446}, "location": {"width": 104, "top": 1146, "height": 21, "left": 876}, "words": "在一项48例使"}, {"probability": {"variance": 0.000712, "average": 0.989934, "min": 0.862941}, "location": {"width": 473, "top": 1169, "height": 22, "left": 328}, "words": "在斑块型银屑病患者中进行的湿关节炎、银屑病关节炎、强直"}, {"probability": {"variance": 4.8e-05, "average": 0.996091, "min": 0.98224}, "location": {"width": 71, "top": 1167, "height": 20, "left": 847}, "words": "剂治疗的中"}, {"probability": {"variance": 3e-06, "average": 0.998497, "min": 0.996075}, "location": {"width": 48, "top": 1168, "height": 17, "left": 970}, "words": "度酒精"}, {"probability": {"variance": 0.000225, "average": 0.994963, "min": 0.917346}, "location": {"width": 503, "top": 1189, "height": 21, "left": 298}, "words": "对照试验表明,在给药的前12周性脊柱炎和银屑病患者的血清中"}, {"probability": {"variance": 2e-06, "average": 0.997995, "min": 0.996171}, "location": {"width": 80, "top": 1186, "height": 20, "left": 846}, "words": "院患者中进"}, {"probability": {"variance": 6.3e-05, "average": 0.995223, "min": 0.972752}, "location": {"width": 196, "top": 1211, "height": 18, "left": 295}, "words": "内本品治疗组患者中约有13"}, {"probability": {"variance": 1.6e-05, "average": 0.998487, "min": 0.984033}, "location": {"width": 228, "top": 1212, "height": 19, "left": 574}, "words": "约6%的患者至少检测出一次抗"}, {"probability": {"variance": 0.022364, "average": 0.917488, "min": 0.55753}, "location": {"width": 127, "top": 1203, "height": 24, "left": 845}, "words": "疗无效,且治宁"}, {"probability": {"variance": 2e-06, "average": 0.998774, "min": 0.996198}, "location": {"width": 139, "top": 1232, "height": 18, "left": 297}, "words": "安慰剂治疗组中约有"}, {"probability": {"variance": 0.000202, "average": 0.991919, "min": 0.943624}, "location": {"width": 229, "top": 1232, "height": 19, "left": 575}, "words": "TNF受体或本品其他蛋白组分的"}, {"probability": {"variance": 0.017211, "average": 0.865536, "min": 0.611298}, "location": {"width": 152, "top": 1223, "height": 23, "left": 846}, "words": "疗组患者的死亡率明"}, {"probability": {"variance": 0, "average": 0.999125, "min": 0.998436}, "location": {"width": 78, "top": 1250, "height": 20, "left": 295}, "words": "射部位反应"}, {"probability": {"variance": 0.002515, "average": 0.984761, "min": 0.811046}, "location": {"width": 210, "top": 1253, "height": 19, "left": 581}, "words": "亢体,这些抗体均非中和抗体"}, {"probability": {"variance": 0.013638, "average": 0.94521, "min": 0.639063}, "location": {"width": 122, "top": 1248, "height": 19, "left": 846}, "words": "荐酒精性肝炎患者"}, {"probability": {"variance": 0.004461, "average": 0.974022, "min": 0.721479}, "location": {"width": 646, "top": 1269, "height": 24, "left": 330}, "words": "上市后曾观察到与本品治疗有接受本品治疗的幼年特发性关节患有中度到重度酒"}, {"probability": {"variance": 0.010701, "average": 0.965006, "min": 0.622883}, "location": {"width": 186, "top": 1292, "height": 22, "left": 299}, "words": "关的注射部位的出血和痰血"}, {"probability": {"variance": 1e-06, "average": 0.99916, "min": 0.996325}, "location": {"width": 230, "top": 1295, "height": 18, "left": 576}, "words": "炎患者的免疫原性检测结果和成"}, {"probability": {"variance": 3.3e-05, "average": 0.997575, "min": 0.976321}, "location": {"width": 227, "top": 1290, "height": 18, "left": 847}, "words": "使用本品治疗时,医生应谨慎使用"}, {"probability": {"variance": 2e-06, "average": 0.998067, "min": 0.995598}, "location": {"width": 60, "top": 1314, "height": 18, "left": 298}, "words": "严重感染"}, {"probability": {"variance": 0.000452, "average": 0.98999, "min": 0.927108}, "location": {"width": 177, "top": 1315, "height": 18, "left": 575}, "words": "年类风湿关节炎患者相似"}, {"probability": {"variance": 0.001314, "average": 0.986361, "min": 0.862786}, "location": {"width": 204, "top": 1333, "height": 19, "left": 328}, "words": "在类风湿关节炎患者的对照试"}, {"probability": {"variance": 0.001343, "average": 0.979971, "min": 0.886842}, "location": {"width": 204, "top": 1335, "height": 20, "left": 601}, "words": "银屑病患者接受本品治疗120"}, {"probability": {"variance": 2e-06, "average": 0.998932, "min": 0.996167}, "location": {"width": 86, "top": 1329, "height": 21, "left": 860}, "words": "般注意事项"}, {"probability": {"variance": 0.000843, "average": 0.988394, "min": 0.844705}, "location": {"width": 585, "top": 1353, "height": 23, "left": 294}, "words": "验中,当本品治疗组和安慰剂组的周,在24周/48周/72周/96感染"}, {"probability": {"variance": 0.000621, "average": 0.991534, "min": 0.875289}, "location": {"width": 510, "top": 1374, "height": 22, "left": 296}, "words": "治疗暴露时间相同时,两组报告严周检测时间点的抗体阳性率为"}, {"probability": {"variance": 0.01236, "average": 0.957461, "min": 0.589785}, "location": {"width": 196, "top": 1378, "height": 21, "left": 880}, "words": "由于本品的平均消除半衰期约"}, {"probability": {"variance": 7.4e-05, "average": 0.994039, "min": 0.968583}, "location": {"width": 235, "top": 1394, "height": 20, "left": 296}, "words": "重感染(致命的、威胁生命的、需"}, {"probability": {"variance": 0.005151, "average": 0.968721, "min": 0.741101}, "location": {"width": 459, "top": 1397, "height": 21, "left": 594}, "words": "6%-8.7%,这些抗体均非中和为70小时(范围:7-300小时"}, {"probability": {"variance": 0.003029, "average": 0.976457, "min": 0.715359}, "location": {"width": 510, "top": 1415, "height": 22, "left": 297}, "words": "要住院的或需要抗生素静脉给药的)抗体。抗体阳性的患者比例随疗"}, {"probability": {"variance": 0.00323, "average": 0.98363, "min": 0.771189}, "location": {"width": 231, "top": 1421, "height": 18, "left": 848}, "words": "因此在使用本品治疗前、治疗中和"}, {"probability": {"variance": 1.4e-05, "average": 0.998103, "min": 0.985166}, "location": {"width": 234, "top": 1436, "height": 18, "left": 296}, "words": "和非严重感染的发生率相当。最常"}, {"probability": {"variance": 0.000104, "average": 0.996292, "min": 0.959937}, "location": {"width": 233, "top": 1436, "height": 22, "left": 575}, "words": "程增加而升高,但该结果的临床"}, {"probability": {"variance": 0.004034, "average": 0.970063, "min": 0.765871}, "location": {"width": 231, "top": 1441, "height": 18, "left": 849}, "words": "治疗后,必须对患者的感染情况进"}, {"probability": {"variance": 0.000244, "average": 0.993094, "min": 0.939827}, "location": {"width": 219, "top": 1456, "height": 19, "left": 295}, "words": "见的非严重感染是上呼吸道感染"}, {"probability": {"variance": 0.000182, "average": 0.995281, "min": 0.945213}, "location": {"width": 289, "top": 1458, "height": 20, "left": 576}, "words": "意义尚不清楚。抗体的产生与临行"}, {"probability": {"variance": 1.8e-05, "average": 0.997692, "min": 0.98375}, "location": {"width": 219, "top": 1477, "height": 18, "left": 296}, "words": "本品治疗达48个月的类风湿关"}, {"probability": {"variance": 0.019684, "average": 0.957471, "min": 0.452233}, "location": {"width": 233, "top": 1478, "height": 21, "left": 575}, "words": "床疗效或不良反应没有明显关联"}, {"probability": {"variance": 0.0001, "average": 0.992629, "min": 0.970829}, "location": {"width": 87, "top": 1481, "height": 18, "left": 882}, "words": "曾有使用本品"}, {"probability": {"variance": 0.00042, "average": 0.977707, "min": 0.957217}, "location": {"width": 29, "top": 1482, "height": 17, "left": 1037}, "words": "感染"}, {"probability": {"variance": 0.007055, "average": 0.981119, "min": 0.553917}, "location": {"width": 496, "top": 1497, "height": 21, "left": 297}, "words": "炎患者中出现严重感染的比例为性。目前尚不清楚接受本品治"}, {"probability": {"variance": 0.023247, "average": 0.953311, "min": 0.383993}, "location": {"width": 233, "top": 1501, "height": 19, "left": 847}, "words": "毒血症、结核病和机会致病菌感"}, {"probability": {"variance": 0.008925, "average": 0.961176, "min": 0.484323}, "location": {"width": 494, "top": 1517, "height": 21, "left": 313}, "words": "3%,包括脓肿(各种部位)、菌超过120周患者的免疫原性发生"}, {"probability": {"variance": 0.002182, "average": 0.973788, "min": 0.856622}, "location": {"width": 232, "top": 1521, "height": 21, "left": 848}, "words": "染(包括侵性真菌感染)的报告"}, {"probability": {"variance": 0.006526, "average": 0.954264, "min": 0.711044}, "location": {"width": 310, "top": 1536, "height": 23, "left": 298}, "words": "血症、支气管炎、滑囊炎、蜂窝组情况"}, {"probability": {"variance": 0.02136, "average": 0.930086, "min": 0.487093}, "location": {"width": 227, "top": 1542, "height": 20, "left": 853}, "words": "参见“不良反应”。这些感染是"}, {"probability": {"variance": 0.003288, "average": 0.97681, "min": 0.767026}, "location": {"width": 234, "top": 1557, "height": 19, "left": 299}, "words": "织炎、胆囊炎、腹泻、憩室炎、心"}, {"probability": {"variance": 0.005684, "average": 0.978628, "min": 0.620508}, "location": {"width": 472, "top": 1559, "height": 23, "left": 608}, "words": "本数据反应的是采用 ELISA由细菌、分枝杆菌、真菌和病毒引"}, {"probability": {"variance": 0.010919, "average": 0.942613, "min": 0.614526}, "location": {"width": 228, "top": 1578, "height": 19, "left": 299}, "words": "内膜炎(疑似)、胃肠炎、乙型肝炎"}, {"probability": {"variance": 2e-06, "average": 0.999068, "min": 0.995142}, "location": {"width": 224, "top": 1580, "height": 20, "left": 578}, "words": "方法检测抗体阳性的患者百分比"}, {"probability": {"variance": 0.001836, "average": 0.97667, "min": 0.881304}, "location": {"width": 87, "top": 1583, "height": 19, "left": 853}, "words": "起的。在某些"}, {"probability": {"variance": 0.00219, "average": 0.967885, "min": 0.878681}, "location": {"width": 78, "top": 1584, "height": 17, "left": 1003}, "words": "由于真菌和"}, {"probability": {"variance": 0.000103, "average": 0.996514, "min": 0.960009}, "location": {"width": 225, "top": 1599, "height": 19, "left": 296}, "words": "带状疱疹、腿部溃疡、口腔感染"}, {"probability": {"variance": 5e-06, "average": 0.998036, "min": 0.993539}, "location": {"width": 196, "top": 1601, "height": 19, "left": 576}, "words": "这些数据很大程度上依赖于"}, {"probability": {"variance": 3.8e-05, "average": 0.995455, "min": 0.976549}, "location": {"width": 231, "top": 1605, "height": 17, "left": 849}, "words": "其他机会致病菌不能被识别导致治"}, {"probability": {"variance": 0.007391, "average": 0.966217, "min": 0.617671}, "location": {"width": 487, "top": 1618, "height": 22, "left": 301}, "words": "骨髓炎、耳炎、腹膜炎、肺炎、肾析方法的灵敏度和特异性。另"}, {"probability": {"variance": 1e-06, "average": 0.999149, "min": 0.996175}, "location": {"width": 227, "top": 1625, "height": 18, "left": 853}, "words": "宁延误,有时导致死亡。在很多报"}, {"probability": {"variance": 0.001687, "average": 0.98204, "min": 0.836996}, "location": {"width": 223, "top": 1639, "height": 21, "left": 299}, "words": "孟肾炎、脓毒血症、脓毒性关节炎"}, {"probability": {"variance": 1e-06, "average": 0.99913, "min": 0.996278}, "location": {"width": 231, "top": 1641, "height": 20, "left": 576}, "words": "除灵敏度和特异性外,分析过程"}, {"probability": {"variance": 0.000613, "average": 0.989451, "min": 0.901146}, "location": {"width": 226, "top": 1646, "height": 19, "left": 854}, "words": "中,患者也同时使用包括免疫抑"}, {"probability": {"variance": 0.002164, "average": 0.988895, "min": 0.744251}, "location": {"width": 510, "top": 1660, "height": 22, "left": 297}, "words": "鼻窦炎、皮肤感染、皮肤溃疡、尿中影响抗体阳性结果判断的其它"}, {"probability": {"variance": 2.2e-05, "average": 0.997987, "min": 0.982735}, "location": {"width": 232, "top": 1667, "height": 17, "left": 848}, "words": "制剂在内的药物治疗。在评估患者"}, {"probability": {"variance": 0.000111, "average": 0.994343, "min": 0.963268}, "location": {"width": 217, "top": 1680, "height": 19, "left": 299}, "words": "道感染、血管炎以及伤口感染等"}, {"probability": {"variance": 0.001506, "average": 0.981774, "min": 0.852754}, "location": {"width": 377, "top": 1682, "height": 22, "left": 576}, "words": "因素还包括测定方法学、样品处感染情况时,相"}, {"probability": {"variance": 0.002146, "average": 0.970751, "min": 0.890593}, "location": {"width": 57, "top": 1687, "height": 17, "left": 1023}, "words": "菌对患者"}, {"probability": {"variance": 0.011986, "average": 0.951786, "min": 0.526166}, "location": {"width": 741, "top": 1701, "height": 26, "left": 298}, "words": "在为期2年的活性对照试验中分别理、取样时间、合并用药和所表的风险也应考虑(如地方性真"}], "language": 3}